Bank of Montreal Can Makes New Investment in agilon health, inc. (NYSE:AGL)

Bank of Montreal Can purchased a new stake in agilon health, inc. (NYSE:AGL) in the second quarter, according to its most recent filing with the SEC. The fund purchased 61,687 shares of the company’s stock, valued at approximately $404,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Wellington Management Group LLP increased its stake in agilon health by 2.9% during the fourth quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after purchasing an additional 1,191,253 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares during the period. Capital International Investors increased its holdings in shares of agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after buying an additional 9,263,296 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock worth $127,256,000 after buying an additional 3,195,087 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after purchasing an additional 174,883 shares during the period.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 3.20% of the company’s stock.

agilon health Price Performance

agilon health stock opened at $3.32 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The business has a 50 day simple moving average of $4.19 and a 200 day simple moving average of $5.32. agilon health, inc. has a one year low of $2.99 and a one year high of $20.37. The company has a market capitalization of $1.37 billion, a PE ratio of -4.74 and a beta of 0.54.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm earned ($0.04) earnings per share. The business’s revenue was up 38.7% on a year-over-year basis. On average, sell-side analysts forecast that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Benchmark restated a “buy” rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price objective on shares of agilon health in a report on Wednesday, August 7th. Finally, Evercore ISI reduced their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday. Two analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $8.03.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.